Peter Whatts, MD

Detroit Medical Center/Wayne State University
Detroit, MI

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3309 - Factors Associated with Completion of Treatment Course with Lutetium-177 Vipivotide Tetraxetan in Men with Metastatic Castration-Resistant Prostate Cancer at a Single Institution

  Tuesday, October 1, 2024
  2:30 PM – 3:45 PM ET